Orphazyme receives offers, begins negotiations with potential buyer
Embattled biotech firm Orphazyme has announced on Friday it has received ”certain non-binding offers,” entailing the full purchase of all of the company’s assets and operations, from several undisclosed parties. (Updated)
by albert rønning-andersson, translated by daniel pedersen
Biotech firm Orphazyme might be taken under someone else’s wing.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
.jpg)
Orphazyme creditors approve restructuring plan
For subscribers
